Cite
HARVARD Citation
Massarelli, E. et al. (2019). High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online].